Home  |  Contact

UniProtKB/Swiss-Prot P10600: Variant p.Cys409Tyr

Transforming growth factor beta-3 proprotein
Gene: TGFB3
Variant information

Variant position:  409
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Cysteine (C) to Tyrosine (Y) at position 409 (C409Y, p.Cys409Tyr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (C) to large size and aromatic (Y)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In LDS5; hypomorphic mutation; results in impaired TGF-beta signaling.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  409
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  412
The length of the canonical sequence.

Location on the sequence:   LYYVGRTPKVEQLSNMVVKS  C KCS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LYYVGRTPKVEQLSNMVVKSCKCS

Mouse                         LYYVGRTPKVEQLSNMVVKSCKCS

Rat                           LYYVGRTPKVEQLSNMVVKSCKCS

Pig                           LYYVGRTAKVEQLSNMVVKSCKCS

Chicken                       LYYVGRTPKVEQLSNMVVKSCKCS

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 301 – 412 Transforming growth factor beta-3
Disulfide bond 344 – 409
Disulfide bond 348 – 411
Alternative sequence 310 – 412 Missing. In isoform 2.
Beta strand 408 – 412


Literature citations

A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome.
Rienhoff H.Y. Jr.; Yeo C.Y.; Morissette R.; Khrebtukova I.; Melnick J.; Luo S.; Leng N.; Kim Y.J.; Schroth G.; Westwick J.; Vogel H.; McDonnell N.; Hall J.G.; Whitman M.;
Am. J. Med. Genet. A 161A:2040-2046(2013)
Cited for: VARIANT LDS5 TYR-409; CHARACTERIZATION OF VARIANT LDS5 TYR-409;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.